✦ LIBER ✦

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer: MONET1

✍ Scribed by Scagliotti, G. V.; Vynnychenko, I.; Park, K.; Ichinose, Y.; Kubota, K.; Blackhall, F.; Pirker, R.; Galiulin, R.; Ciuleanu, T.-E.; Sydorenko, O.; Dediu, M.; Papai-Szekely, Z.; Banaclocha, N. M.; McCoy, S.; Yao, B.; Hei, Y.-j.; Galimi, F.; Spigel, D. R.

Book ID: 125518996
Publisher: American Society of Clinical Oncology
Year: 2012
Tongue: English
Weight: 242 KB
Volume: 30
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2011.41.4987

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III study (MONET1) of motesanib pl

Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis

✍ Kubota, K.; Ichinose, Y.; Scagliotti, G.; Spigel, D.; Kim, J. H.; Shinkai, T.; T 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 273 KB

9007 Randomized, double-blind phase II/I

9007 Randomized, double-blind phase II/III study of first-line paclitaxel (P) plus carboplatin (C) in combination with vorinostat or placebo in patients with advanced non-small-cell lung cancer (NSCLC)

✍ Belani, C.; Ramalingam, S.; Kalemkerian, G.; Mok, T.; Rosell, R.; Ahn, M.J.; Sun 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

9165 Motesanib or bevacizumab in combina

9165 Motesanib or bevacizumab in combination with paclitaxel and carboplatin in patients with advanced nonsquamous non-small cell lung cancer (NSCLC): interim results from a randomized, open-label, phase 2 study

✍ Blumenschein, G.; Schwartzberg, L.S.; Menon, H.; Mok, T.S.K.; Stephenson, J.J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Rationale and Design of MARQUEE: A Phase

Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer

✍ Giorgio V. Scagliotti; Silvia Novello; Joan H. Schiller; Vera Hirsh; Lecia V. Se 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 332 KB

Phase 2 study of S-1 plus carboplatin in

Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer

✍ Kaira, Kyoichi; Sunaga, Noriaki; Yanagitani, Noriko; Imai, Hisao; Utsugi, Mitsuy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Phase III, Randomized, Double-Blind, Pla

Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non-Small-Cell Lung Cancer

✍ Paz-Ares, L. G.; Biesma, B.; Heigener, D.; von Pawel, J.; Eisen, T.; Bennouna, J 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 163 KB